Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05111392Phase 2Completed
Phase 2, randomised, single-blind trial (3 arms), sponsored by University of Illinois Chicago. Primary endpoint: Rate of appearance of deuterium in the plasma at 2 hours. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05111392.